Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Agreement Between Multidisciplinary Cancer Board Decisions and ChatGPT-4O in Clinical Decision-Making: A Cross-Sectional Observational Study

NCT06986564 is registered in ClinicalTrials.gov with Sebahattin Celik MD as lead sponsor.

NCT NCT06986564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06986564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Agreement Between Multidisciplinary Cancer Board Decisions and ChatGPT-4O in Clinical Decision-Making: A Cross-Sectional Observational Study
Lead sponsor
Sebahattin Celik MD
Phase
Observational
Overall status
Completed
Start date
November 1, 2024
Completion date
May 1, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence, cancer